Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program

被引:81
|
作者
Marshall, Deborah C. [1 ,2 ]
Jackson, Madeleine E. [2 ]
Hattangadi-Gluth, Jona A. [1 ]
机构
[1] Univ Calif San Diego, Dept Radiat Med & Appl Sci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
CONFLICT-OF-INTEREST; SUNSHINE ACT; CONSEQUENCES; STATE; US;
D O I
10.1016/j.mayocp.2015.10.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Centers for Medicare and Medicaid Services' Open Payments program implements Section 6002 of the Affordable Care Act requiring medical product manufacturers to report payments made to physicians or teaching hospitals as well as ownership or investment interests held by physicians in the manufacturer. To determine the characteristics and distribution of these industry payments by specialty, we analyzed physician payments made between August 1, 2013, and December 31, 2013, that were publicly disclosed by Open Payments. We compared payments between specialty types (medical, surgical, and other) and across specialties within each type using the Pearson chi(2) test and the Kruskal-Wallis test. The number of physicians receiving payments was compared with the total number of active physicians in each specialty in 2012. We also analyzed physician ownership interests. Allopathic and osteopathic physicians received 2.43 million payments totaling $475 million. General payments represented 90% of payments by total value ($430 million) (per-physician median, $100; interquartile range [IQR], $31-$273; mean +/- SD, $1407 +/- $23,766), with the remaining 10% ($45 million) as research payments (median, $2365; IQR, $592-$8550; mean +/- SD, $12,880 +/- $66,743). Physicians most likely to receive general payments were cardiovascular specialists (78%) and neurosurgeons (77%); those least likely were pathologists (9%). Reports of ownership interest in reporting entities included $310 million in dollar amount invested and $447 million in value of interest held by 2093 physicians. In conclusion, the distribution and characteristics of industry payments to physicians varied widely by specialty during the first half-year of Open Payments reporting. (C) 2016 Mayo Foundation for Medical Education and Research
引用
收藏
页码:84 / 96
页数:13
相关论文
共 50 条
  • [41] Types and Distribution of Payments From Industry to Physicians in 2015
    Tringale, Kathryn R.
    Marshall, Deborah
    Mackey, Tim K.
    Connor, Michael
    Murphy, James D.
    Hattangadi-Gluth, Jona A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (17): : 1774 - 1784
  • [42] Open Payments Program Inclusion of Nurse Practitioner Data
    Harrington, Frank
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (09): : 931 - 932
  • [43] OPEN PAYMENTS PROGRAM Response
    Law, Alan S.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2022, 153 (09): : 822 - 823
  • [44] Industry payments to academic neurosurgeons in 2021 an open payments cross-sectional analysis
    Debs, Luca H.
    Mansouri, Seena
    Ledford, W. Luke
    Woodall, William
    Vale, Fernando L.
    JOURNAL OF NEUROSURGERY, 2024, 141 (03) : 815 - 821
  • [45] Industry Payments Among Appropriate Use Criteria Voting Panels An Open Payments Analysis
    Acuna, Alexander J.
    Jella, Tarun K.
    Barksdale, I. I. I. Edward M.
    Samuel, Linsen T.
    Kamath, Atul F.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2022, 104 (04): : E11
  • [46] Industry Payments for Otolaryngology Research: A Four-Year Analysis of the Open Payments Database
    Brauer, Philip R.
    Morse, Elliot
    Mehra, Saral
    LARYNGOSCOPE, 2020, 130 (02): : 314 - 320
  • [47] Disclosure of Industry Payments to Prescribers: Industry Payments Might Be a Factor Impacting Generic Drug Prescribing
    Qian, Jingjing
    Hansen, Richard
    Surry, Daniel
    Howard, Jennifer
    Kiptanui, Zippora
    Harris, Ilene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 37 - 37
  • [48] CMS Open Payments Database Analysis of Industry Payments for Foot and Ankle Surgery Research
    Casciato, Dominick J.
    Mendicino, Robert W.
    JOURNAL OF FOOT & ANKLE SURGERY, 2022, 61 (05): : 1013 - 1016
  • [49] Pharmaceutical company payments to physicians - Early experiences with disclosure laws in Vermont and Minnesota
    Ross, Joseph S.
    Lackner, Josh E.
    Lurie, Peter
    Gross, Cary P.
    Wolfe, Sidney
    Krumholz, Harlan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (11): : 1216 - 1223
  • [50] Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing
    Qian, Jingjing
    Hansen, Richard A.
    Surry, Daniel
    Howard, Jennifer
    Kiptanui, Zippora
    Harris, Ilene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (07) : 819 - 826